| Gene symbol | PMEL | Synonyms | D12S53E, HMB-45, HMB45, ME20, ME20-M, ME20M, P1, P100, PMEL17, SI, SIL, SILV, gp100 | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12q13.2 | dbXrefs | |
| Description | premelanosome protein | ||||
| GTO ID | GTC1964 |
| Trial ID | NCT03649529 |
| Disease | Malignant Adenoma |
| Altered gene | gp100 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPA-TriMAR-T |
| Generation | 2nd |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy |
| Year | 2018 |
| Country | China |
| Company sponsor | Timmune Biotech Inc. |
| Other ID(s) | T2018-7 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||